M. Boyer

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer

M. Stockler, N. Pavlakis, S. Clark, 2014, British Journal of Cancer.

Randomized cross‐over trial comparing inpatient and outpatient administration of high‐dose cisplatin

M. Stockler, R. Simes, K. Cox, 2011, Internal medicine journal.

Weekly docetaxel as second line treatment after mitozantrone for androgen‐independent prostate cancer

M. Stockler, S. Clarke, A. Joshua, 2005, Internal medicine journal.

Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29.

M. Stockler, L. Seymour, K. Ding, 2014, European journal of cancer.

Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer

M. Stockler, M. Chatfield, S. Clark, 2014, British Journal of Cancer.

Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer

M. Stockler, M. Chatfield, N. Pavlakis, 2015, British Journal of Cancer.

Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non‐small‐cell lung cancer

M. Stockler, P. Blinman, G. McCaughan, 2013, Internal medicine journal.

An elusive tumor in a man who has evidence of prostate cancer metastasis.

M. Boyer, B. Boyer, 2009, JAAPA : official journal of the American Academy of Physician Assistants.